ORAGENICS, INC. Increase (Decrease) in Inventories
ORAGENICS, INC. (OGEN) reported Increase (Decrease) in Inventories of -$80.03 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2016-05-16
- ORAGENICS, INC. increase (decrease) in inventories for the quarter ending 2016-03-31 was -$80.03K.
- ORAGENICS, INC. increase (decrease) in inventories for the quarter ending 2015-12-31 was $22.19K, a 87.34% decline year-over-year.
- ORAGENICS, INC. increase (decrease) in inventories for the quarter ending 2015-09-30 was -$64.76K, a 360.23% decline year-over-year.
- ORAGENICS, INC. increase (decrease) in inventories for the quarter ending 2015-06-30 was -$12.94K.
- ORAGENICS, INC. increase (decrease) in inventories for fiscal 2015 was -$117.68K, a 178.03% decline from fiscal 2014.
- ORAGENICS, INC. increase (decrease) in inventories for fiscal 2014 was $150.81K, a 8.16% decline from fiscal 2013.
- ORAGENICS, INC. increase (decrease) in inventories for fiscal 2013 was $164.21K.
- ORAGENICS, INC. increase (decrease) in inventories for fiscal 2012 was -$351.41K, a 268.17% decline from fiscal 2011.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2016-03-31 | -$80.03K 10-Q · filed 2016-05-16 | -$57.83K derived: sum of 2 quarters · filed 2016-05-16 | -$122.59K derived: sum of 3 quarters · filed 2016-05-16 | -$135.53K derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-12-31 | $22.19K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$42.56K derived: sum of 2 quarters · filed 2016-03-30 | -$55.51K derived: sum of 3 quarters · filed 2016-03-30 | -$117.68K 10-K · filed 2016-03-30 |
| 2015-09-30 | -$64.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$77.70K derived: sum of 2 quarters · filed 2015-11-06 | -$139.87K 10-Q · filed 2015-11-06 | $35.46K derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-06-30 | -$12.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$75.11K 10-Q · filed 2015-08-07 | $100.21K derived: sum of 3 quarters · filed 2016-05-16 | $125.10K derived: sum of 4 quarters · filed 2016-05-16 |
| 2015-03-31 | -$62.17K 10-Q · filed 2016-05-16 | $113.16K derived: sum of 2 quarters · filed 2016-05-16 | $138.04K derived: sum of 3 quarters · filed 2016-05-16 | $111.13K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | $175.33K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $200.21K derived: sum of 2 quarters · filed 2016-03-30 | $173.31K derived: sum of 3 quarters · filed 2016-03-30 | $150.81K 10-K · filed 2016-03-30 |
| 2014-09-30 | $24.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$2.02K derived: sum of 2 quarters · filed 2015-11-06 | -$24.52K 10-Q · filed 2015-11-06 | $280.55K derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-06-30 | -$26.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$49.41K 10-Q · filed 2015-08-07 | $255.66K derived: sum of 3 quarters · filed 2015-08-07 | $175.98K derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-03-31 | -$22.50K 10-Q · filed 2015-05-08 | $282.57K derived: sum of 2 quarters · filed 2015-05-08 | $202.88K derived: sum of 3 quarters · filed 2015-05-08 | $148.62K derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $305.07K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $225.38K derived: sum of 2 quarters · filed 2015-02-27 | $171.12K derived: sum of 3 quarters · filed 2015-02-27 | $164.21K 10-K · filed 2015-02-27 |
| 2013-09-30 | -$79.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | -$133.95K derived: sum of 2 quarters · filed 2014-11-03 | -$140.87K 10-Q · filed 2014-11-03 | -$296.64K derived: sum of 4 quarters · filed 2014-11-03 |
| 2013-06-30 | -$54.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$61.18K 10-Q · filed 2014-08-07 | -$216.95K derived: sum of 3 quarters · filed 2014-08-07 | -$290.82K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | -$6.91K 10-Q · filed 2014-05-09 | -$162.68K derived: sum of 2 quarters · filed 2014-05-09 | -$236.56K derived: sum of 3 quarters · filed 2014-05-09 | -$245.72K derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | -$155.77K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$229.64K derived: sum of 2 quarters · filed 2014-02-28 | -$238.81K derived: sum of 3 quarters · filed 2014-02-28 | -$351.41K 10-K · filed 2014-02-28 |
| 2012-09-30 | -$73.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | -$83.04K derived: sum of 2 quarters · filed 2013-10-25 | -$195.64K 10-Q · filed 2013-10-25 | -$185.53K derived: sum of 4 quarters · filed 2013-10-25 |
| 2012-06-30 | -$9.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$121.77K 10-Q · filed 2013-08-12 | -$111.65K derived: sum of 3 quarters · filed 2013-08-12 | -$146.74K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | -$112.61K 10-Q · filed 2013-05-15 | -$102.49K derived: sum of 2 quarters · filed 2013-05-15 | -$137.58K derived: sum of 3 quarters · filed 2013-05-15 | $87.97K derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $10.12K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | -$24.97K derived: sum of 2 quarters · filed 2013-03-26 | $200.57K derived: sum of 3 quarters · filed 2013-03-26 | $208.96K 10-K · filed 2013-03-26 |
| 2011-09-30 | -$35.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $190.46K derived: sum of 2 quarters · filed 2012-11-14 | $198.85K 10-Q · filed 2012-11-14 | $92.05K derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $225.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $233.94K 10-Q · filed 2012-08-10 | $127.14K derived: sum of 3 quarters · filed 2012-08-10 | $84.09K derived: sum of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | $8.39K 10-Q · filed 2012-05-15 | -$98.40K derived: sum of 2 quarters · filed 2012-05-15 | -$141.46K derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | -$106.79K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$149.85K derived: sum of 2 quarters · filed 2012-04-16 | $134.52K 10-K · filed 2012-04-16 | |
| 2010-09-30 | -$43.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $241.31K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $284.36K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |